Fluorouracil-figure-1 (Fluorouracil Fig1)
Fluorouracil Injection, Solution
Product Images NDC 55150-499
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Fluorouracil (NDC 55150-499). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Package Label-principal Display Panel (2.5 g/50 mL (50 mg/mL))
Description: This text provides information about a Pharmacy Bulk Package of Fluorouracil Injection, USP with a concentration of 50 mg/mL for intravenous use only. It includes storage instructions, precautions, and usage guidelines such as appropriate handling, time limits for transferring contents, and discarding after initial closure puncture. The product is manufactured in India for Eugia US LLC.*
Package Label-principal Display Panel (2.5 g/50 mL (50 mg/mL))
This is a description of Fluorouracil Injection, USP, a pharmacy bulk package used as a cytotoxic agent for intravenous use only. It is sterile and should be stored at room temperature, protected from light, and not frozen. The package includes instructions for usage, dosage, proper handling, and disposal. The product is distributed by Eugia US LLC and contains Fluorouracil as the active ingredient. It is a prescription drug and is not for direct infusion.*
Package Label-principal Display Panel (5 g/100 mL (50 mg/mL))
This is a description for a prescription medication labeled as "Rx only" that is intended for intravenous use. It is a sterile CYTOTOXIC AGENT used for medical purposes. The text provides instructions on how to prepare and utilize the medication properly, including details on temperature control, fluid transfer processes, and expiration timelines. Additionally, it gives information on inactive ingredients and pH adjustments. The medication is manufactured in India for Eugia US LLC in E. Windsor, NJ. The package insert is recommended for complete dosage information and container use.*
Package Label-principal Display Panel (5 g/100 mL (50 mg/mL))
This is a description of Fluorouracil Injection, USP in the form of a pharmacy bulk package, labeled as a cytotoxic agent for intravenous use only. The product should be stored at controlled room temperature, protected from light, and not frozen. The vial stopper is latex-free. Instructions for dosage preparation are provided, including the use of sterile equipment and a maximum 4-hour time limit for transferring operations after initial entry. The package insert contains more detailed dosage information. The active ingredient is 50 mg/mL of Fluorouracil, with sodium hydroxide for pH adjustment, and no preservative. Distributed by Eugia US LLC and manufactured in India. In case of precipitation due to low temperatures, the solution can be resolubilized by heating and shaking.*
Fluorouracil-structure (Fluorouracil Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
